Activation of the PBX2‐PRMT1‐SWI/SNF‐IGF2BP2 Signaling Pathway is Associated with Malignant Progression and Poor Prognosis of HNSCC. This evidence concerns the gene PRMT1 and head and neck squamous cell carcinoma.